431 related articles for article (PubMed ID: 27956145)
1. Recent advances in preclinical model systems for papillomaviruses.
Christensen ND; Budgeon LR; Cladel NM; Hu J
Virus Res; 2017 Mar; 231():108-118. PubMed ID: 27956145
[TBL] [Abstract][Full Text] [Related]
2. Animal models of papillomavirus pathogenesis.
Campo MS
Virus Res; 2002 Nov; 89(2):249-61. PubMed ID: 12445664
[TBL] [Abstract][Full Text] [Related]
3. Developments in L2-based human papillomavirus (HPV) vaccines.
Schellenbacher C; Roden RBS; Kirnbauer R
Virus Res; 2017 Mar; 231():166-175. PubMed ID: 27889616
[TBL] [Abstract][Full Text] [Related]
4. Rodent Papillomaviruses.
Uberoi A; Lambert PF
Viruses; 2017 Nov; 9(12):. PubMed ID: 29186900
[TBL] [Abstract][Full Text] [Related]
5. The cottontail rabbit papillomavirus model of high-risk HPV-induced disease.
Brandsma JL
Methods Mol Med; 2005; 119():217-35. PubMed ID: 16350405
[TBL] [Abstract][Full Text] [Related]
6. Preclinical model to test human papillomavirus virus (HPV) capsid vaccines in vivo using infectious HPV/cottontail rabbit papillomavirus chimeric papillomavirus particles.
Mejia AF; Culp TD; Cladel NM; Balogh KK; Budgeon LR; Buck CB; Christensen ND
J Virol; 2006 Dec; 80(24):12393-7. PubMed ID: 17005666
[TBL] [Abstract][Full Text] [Related]
7. The current state of therapeutic and T cell-based vaccines against human papillomaviruses.
Yang A; Farmer E; Lin J; Wu TC; Hung CF
Virus Res; 2017 Mar; 231():148-165. PubMed ID: 27932207
[TBL] [Abstract][Full Text] [Related]
8. The rabbit viral skin papillomas and carcinomas: a model for the immunogenetics of HPV-associated carcinogenesis.
Breitburd F; Salmon J; Orth G
Clin Dermatol; 1997; 15(2):237-47. PubMed ID: 9167908
[No Abstract] [Full Text] [Related]
9. Protection against papillomavirus with a polynucleotide vaccine.
Donnelly JJ; Martinez D; Jansen KU; Ellis RW; Montgomery DL; Liu MA
J Infect Dis; 1996 Feb; 173(2):314-20. PubMed ID: 8568291
[TBL] [Abstract][Full Text] [Related]
10. Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles.
Boxus M; Fochesato M; Miseur A; Mertens E; Dendouga N; Brendle S; Balogh KK; Christensen ND; Giannini SL
J Virol; 2016 Jul; 90(14):6314-25. PubMed ID: 27147749
[TBL] [Abstract][Full Text] [Related]
11. Vesicular stomatitis virus-based therapeutic vaccination targeted to the E1, E2, E6, and E7 proteins of cottontail rabbit papillomavirus.
Brandsma JL; Shylankevich M; Su Y; Roberts A; Rose JK; Zelterman D; Buonocore L
J Virol; 2007 Jun; 81(11):5749-58. PubMed ID: 17392369
[TBL] [Abstract][Full Text] [Related]
12. Papillomavirus vaccines.
Duggan-Keen MF; Brown MD; Stacey SN; Stern PL
Front Biosci; 1998 Dec; 3():D1192-208. PubMed ID: 9835649
[TBL] [Abstract][Full Text] [Related]
13. Regulation of immune responses to HPV infection and during HPV-directed immunotherapy.
Bhat P; Mattarollo SR; Gosmann C; Frazer IH; Leggatt GR
Immunol Rev; 2011 Jan; 239(1):85-98. PubMed ID: 21198666
[TBL] [Abstract][Full Text] [Related]
14. Postattachment neutralization of papillomaviruses by monoclonal and polyclonal antibodies.
Christensen ND; Cladel NM; Reed CA
Virology; 1995 Feb; 207(1):136-42. PubMed ID: 7871722
[TBL] [Abstract][Full Text] [Related]
15. Modeling HPV-Associated Disease and Cancer Using the Cottontail Rabbit Papillomavirus.
Cladel NM; Xu J; Peng X; Jiang P; Christensen ND; Zheng ZM; Hu J
Viruses; 2022 Sep; 14(9):. PubMed ID: 36146770
[TBL] [Abstract][Full Text] [Related]
16. Biology and pathological associations of the human papillomaviruses: a review.
Cheah PL; Looi LM
Malays J Pathol; 1998 Jun; 20(1):1-10. PubMed ID: 10879257
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic Vaccine Against Primate Papillomavirus Infections of the Cervix.
Ragonnaud E; Andersson AC; Mariya S; Pedersen AG; Burk RD; Folgori A; Colloca S; Cortese R; Nicosia A; Pamungkas J; Iskandriati D; Holst PJ
J Immunother; 2017; 40(2):51-61. PubMed ID: 28166180
[TBL] [Abstract][Full Text] [Related]
18. [Advances in Understanding Carcinogenetic Mechanisms of the Human Papillomavirus and Vaccines Based on Virus-like Particles].
Zhao Z; Wang L; Ma B
Bing Du Xue Bao; 2015 Mar; 31(2):180-6. PubMed ID: 26164945
[TBL] [Abstract][Full Text] [Related]
19. [Immune response in cervical cancer. Strategies for the development of therapeutic vaccines].
Mora-García ML; Monroy-García A
Rev Med Inst Mex Seguro Soc; 2015; 53 Suppl 2():S206-11. PubMed ID: 26462518
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus vaccines for the prevention and treatment of cervical cancer.
Tomson TT; Roden RB; Wu TC
Curr Opin Investig Drugs; 2004 Dec; 5(12):1247-61. PubMed ID: 15648945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
